Akums Drugs and Pharmaceuticals Limited IPO (Akums Drugs and Pharmaceuticals IPO)

A pharmaceutical contract development and manufacturing organization (CDMO), Akums Drugs and Pharmaceuticals Limited was founded in 2004 and provides a wide range of pharmaceutical goods and services both domestically in India and internationally.

Beyond creating and producing products, the company also researches new formulas, develops product information, and handles all necessary paperwork to sell products both in India and overseas markets, and offers other testing services. The business also manufactures and sells branded medications and active pharmaceutical ingredients (APIs).

As a CDMO, the company produces a broad variety of dosage forms, such as gummy bears, dry powder injections, topical preparations, eye drops, vials, ampoules, tablets, capsules, and liquid medications, to mention a few.

Over 60 different dosage forms and 4,025 marketable formulations have been generated by the business. The company produced formulations for 26 of the top 30 pharmaceutical companies in India based on revenue during the 2023 fiscal year. The company operates 10 manufacturing plants dedicated to contract manufacturing. Combined, they can produce a massive 49.21 billion units for its CDMO division (as of September 30, 2023).

With the commissioning of two more production units for its CDMO business in FY 2025, the company intends to increase its production capacity. A number of international regulatory organizations, including the United States National Sanitation Foundation (US NSF), the World Health Organization (WHO-GMP), and the European Good Manufacturing Practice (EU-GMP), have accredited several of its production facilities.

Akums Drugs and Pharmaceuticals employed 16,463 people in total as of September 30, 2023, comprising 7,211 full-time workers and 9,252 contract workers.

Akums Drugs and Pharmaceuticals Limited IPO

The book-built issue of Akums Drugs and Pharmaceuticals is valued at Rs 1,856.74 crores. The offering consists of 1.73 crore shares for sale, totaling Rs 1,176.74 crores, and a new issue of 1 crore shares, totaling Rs 680.00 crores.

The subscription period for Akums Drugs & Pharmaceuticals IPO begins on July 30, 2024, and ends on August 1, 2024. On Friday, August 2, 2024, the allotment for the Akums Drugs & Pharmaceuticals IPO is anticipated to be completed. The tentative listing date for Akums Drugs & Pharmaceuticals IPO is Tuesday, August 6, 2024, and it will take place on the BSE and NSE.

The IPO price range for Akums Drugs & Pharmaceuticals is ₹646 to ₹679 per share. Applications must have a minimum lot size of 22 shares. Retail investors must invest a minimum of ₹14,938 to participate. For both sNII and bNII, the minimum lot size investment is ₹209,132 for 14 lots (308 shares) and ₹1,000,846 for 67 lots (1,474 shares) respectively.

Akums Drugs and Pharmaceuticals Limited IPO Objective

The following goals are to be funded with the Net Proceeds, according to the Company’s proposal:

• Repayment or payback of the company’s debt, as well as the debts of its subsidiaries
• Financing the company’s increased working capital needs
• Pursuing acquisition-based inorganic growth plan
• General corporate purposes: The remaining funds will be used for various corporate needs, such as business development, capital expenditures, and other strategic initiatives.

Akums Drugs and Pharmaceuticals Limited IPO Details

Open and Close Date of Akums Drugs and Pharmaceuticals IPO

The subscription for the IPO will be open from 30th July and will close on 1st August, 2024.

Akums Drugs and Pharmaceuticals IPO Share Price

The price band for the Akums Drugs and Pharmaceuticals IPO has been set at ₹646 to ₹679 per share.

Akums Drugs and Pharmaceuticals IPO Issue Type, Face Value, IPO Price, Market Lot, Listing, Total Issue Size

Akums Drugs and Pharmaceuticals Limited IPO Promoter Holding

The promoters of  Akums Drugs and Pharmaceuticals are Sanjeev Jain, Sandeep Jain, and Akums Master Trust

Akums Drugs and Pharmaceuticals Limited’ Financial Information (Restated Consolidated)

Akums Drugs and Pharmaceuticals Limited IPO Registrar

Link Intime India Private Ltd
Phone: +91-22-4918 6270
Email: akumsdrugs.ipo@linkintime.co.in
Website: https://linkintime.co.in/initial_offer/public-issues.html

Contact Information

Akums Drugs and Pharmaceuticals Limited
304, Mohan Place,
LSC Saraswati Vihar,
Delhi – 110 034
Phone: +91 11 6904 1000
Email: cs@akums.net
Website: http://www.akums.in/

Akums Drugs and Pharmaceuticals Limited IPO Prospectus

Akums Drugs and Pharmaceuticals IPO DRHP

Akums Drugs and Pharmaceuticals IPO RHP

Anchor Investors in Akums Drugs and Pharmaceuticals IPO

Read this before buying Gold Online.